The Pilot and Feasibility Program, a vital component of the Diabetes Research Center, provides initial support for new investigators, allows established investigators to explore new directions, and enables the DRC to attract scientists from other disciplines to diabetes research. Over the past 32 years the DRC has funded 90 feasibility studies.
Pilot and Feasibility funds enable investigators to generate preliminary data to provide the basis for seeking extramural funding for their projects.
Eligibility for Feasibility Study Funding
- Applicants must be faculty members of Einstein College of Medicine.
- New faculty members are eligible irrespective of rank or past interests provided that their proposed P&F Studies do not overlap with concurrent extramural funding. Awarded funds are supplemental to resources provided to new recruits by the institution as "start-up packages". Awarded funds are mandated to enrich and promote diabetes research and cannot be used to fulfill institutional recruitment commitments.
- Established Einstein DRC investigators are eligible provided that the proposed study adapts their expertise to a new focus of diabetes research or, alternatively, represents a significant and substantial departure from their current diabetes-related investigations.
- All diabetes-related subject matter is acceptable. Research related to the Prevention and Control Division (P&C) is desirable.
Application for 2013-2014 Pilot and Feasibility Awards
Applications are now being accepted for 2013 Pilot and Feasibility awards. This year, we are particularly interested in applications using metabolomic approaches that are applied to diabetes related research projects.
Fund Application Instructions
Recent Pilot and Feasibility Program Studies
- Herbert Tanowitz, MD
Chagas Diseases and Diabetes
- Bhaskar Das, PhD
A Novel Role of SIRT1 in Regulating Lipid Homeostasis
- Fajun Yang, PhD
Mechanisms of CDK8 Regulation on Lipogenesis
- Claire Bastie, PhD
Fyn Kinase-Dependent Regulation of LKB1
- Laura Bocai, MD
Effect of Insulin on Cardiovascular Complications of Type 2 Diabetes in ACCORD
- Jeffrey Gonzalez, PhD
Reducing Distress and Improving Treatment Adherence in Type 1 Diabetes.
- Liang Zhu, MD, PhD
Role of Rb In Obesity and Diabetes Through Regulation of Hypothalamic Neurons.
- Richard Kitsis, MD
ARC and Beta-Cell Apoptosis: Molecular Mechanisms and Physiological Significance
- Steve Almo, PhD
Multivalent Peptide-MHC Constructs for Treating Diabetes
- Tao Wang, PhD
Genetic Link Between Type 2 diabetes and Postmenopausal Breast Cancer
- David Silver, PhD
Role of FIT Proteins in Obesity and Insulin Resistance